Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein

Class:Id	LiteratureReference:2028252
_displayName	Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein
_timestamp	2011-12-23 21:40:22
author	[Person:2028250] Zhao, B [Person:2028245] Li, L [Person:2028249] Lu, Q [Person:421073] Wang, LH [Person:381003] Liu, CY [Person:2028241] Lei, Q [Person:111055] Guan, KL
created	[InstanceEdit:2028235] D'Eustachio, P, 2011-12-23
journal	Genes Dev
pages	51-63
pubMedIdentifier	21205866
title	Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein
volume	25
year	2011
(literatureReference)	[RegulationReference:9641435] Positive regulation by 'AMOT proteins [cytosol]' Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor [RegulationReference:9641983] Positive regulation by 'AMOT proteins [cytosol]' Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein [Reaction:2028583] Phosphorylation of YAP by LATS2 [Homo sapiens] [Reaction:2028661] Phosphorylation of WWTR1 (TAZ) by LATS2 [Homo sapiens]
[Change default viewing format]

No pathways have been reviewed or authored by Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein (2028252)